Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02178163 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung Cancer

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Enrollment reduced 39% 1020 → 619 participants
See other at-risk trials from Barbara Ann Karmanos Cancer Institute

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment reduced: 1020 → 619 participants
    • Enrollment closed, study ongoing
    • Site details revised at 11 of 11 sites
    v18
  2. Primary and study completion dates: Jul 2026 to Jul 2027
    • Site contacts updated at 8 of 11 sites
    v17
  3. Primary and study completion dates: Jul 2024 to Jul 2026
    • Start date: Jun 2014 to Aug 1, 2014
    • Study sites: 10 to 11
    v16
  4. Enrollment target: 96 to 1020
    • Primary and study completion dates: Jun 2023 to Jul 2024
    • Study sites: 3 to 10
    v15
  5. Primary completion date: Jun 2022 to Jun 2023v14
Show 12 earlier versionsHide 12 earlier versions
  1. Primary completion date: Mar 2022 to Jun 2022
    • Study completion date: Mar 2022 to Jun 2023
    • Site contacts updated at 1 of 3 sites
    v13
  2. Primary and study completion dates: Dec 2019 to Mar 2022
    • Site contacts updated at 1 of 3 sites
    v12
  3. Primary and study completion dates: Dec 2018 to Dec 2019v11
  4. Primary and study completion dates: Dec 2017 to Dec 2018
    • Study sites: 1 to 3
    v10
  5. Site contact updatedv9
  6. Primary and study completion dates: Apr 2017 to Dec 2017v8
  7. Phase: Phase 2 to Not applicablev7
  8. Eligibility criteria shortened, about 95 words
    • Site contact updated
    v6
  9. Primary and study completion dates: Apr 2016 to Apr 2017v5
  10. Eligibility criteria expanded, about 47 wordsv4
  11. Re-verified, no change to tracked fieldsv3
  12. Collaborators: 2 to 1v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This research trial studies comprehensive genomic analysis in tissue samples from patients with non-small cell lung cancer that has come back or is stage IV. Comprehensive genomic analysis may identify specific gene mutations (changes in deoxyribonucleic acid \[DNA\]) and help doctors to tailor treatment to target the specific mutations.
Trial Details
NCT Number NCT02178163
Lead Sponsor Barbara Ann Karmanos Cancer Institute
Collaborators: National Cancer Institute (NCI)
Conditions
(from sponsor)		 Recurrent Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
Related terms Carcinoma, Non-Small-Cell Lung
Enrollment 619 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov